Overview

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.
Phase:
Phase 2
Details
Lead Sponsor:
RSPR Pharma AB